Effect of the COVID-19 pandemic on the ability of level 1 trauma centers to meet American College of Surgeons research requirements

Article Figures & Data

Table 1

ACS-verified level 1 trauma centers and the effect of COVID-19 on research activities

	All n=40	Academic n=34 (85%)	Non-academic n=6 (15%)	Total responses
Facility characteristics
Type of facility				40
Academic	34 (85%)	–	–
Non-academic	6 (15%)	–	–
Profit status				39
Non-profit	32 (82%)	29 (88%)	3 (50%)
For profit	2 (5%)	0 (0%)	2 (33%)
Government	5 (13%)	4 (12%)	1 (17%)
Part of a hospital system	34 (85%)	28 (82%)	6 (100%)	40
Total licensed beds (median (IQR), range)	509 (400–700), 249–1000	545 (400–710), 249–1000	440 (330–600), 250–800	38
Approximate adult trauma admissions in the past 12 months (median (IQR), range)	2300 (1500–3000), 1200–4800	2190 (1450–3100), 1200–4800	2450 (1500–3000), 1500–3100	38
Years of ACS level 1 verification (median (IQR), range)	20 (7–28), 1–36	20 (7–28), 1–36	14 (4–28), 3–30	40
Effects of the COVID-19 pandemic
Trauma service admissions reduced during COVID-19	14 (52%)	11 (52%)	3 (50%)	27
Admission reductions to levels below those required for level 1 verification	2 (7%)	2 (10%)	0 (0%)	27
Scheduled for review during March to December 2020	14 (52%)	12 (57%)	2 (33%)	27
Resource diversion from research during COVID-19	12 (44%)	9 (43%)	3 (50%)	27
Consenting studies postponed during COVID-19	10 (37%)	7 (33%)	3 (50%)	27
Competing priorities during COVID-19 have made it difficult to fulfill level 1 requirements	10 (40%)	8 (42%)	2 (33%)	25

Supplementary Data

This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Data supplement 1